Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
CESC | rs1005805 | chr10:135092100 | A/G | 4.12E-10 | 298 | 7.47 | 20.23 | 21.4 | KM Plot |
CESC | rs1005806 | chr10:135091981 | A/G | 4.12E-10 | 298 | 7.47 | 20.23 | 21.4 | KM Plot |
CESC | rs10114623 | chr9:115631360 | G/A | 3.32E-5 | 298 | 4.22 | 21.18 | 22.45 | KM Plot |
CESC | rs10130766 | chr14:55977524 | C/G | 2.39E-5 | 299 | 18.98 | 24.3 | 20.43 | KM Plot |
CESC | rs10513564 | chr3:161059762 | A/G | 6.72E-5 | 299 | 25.03 | 21.13 | 19.05 | KM Plot |
CESC | rs10515246 | chr5:96099265 | A/G | 9.53E-6 | 296 | 21.17 | 25.33 | 5.1 | KM Plot |
CESC | rs10515249 | chr5:96125259 | G/A | 1.4E-6 | 299 | 21.33 | 24.08 | 6.73 | KM Plot |
CESC | rs1054776 | chr10:135055349 | A/G | 1.89E-14 | 295 | 21.73 | 17.07 | 3.33 | KM Plot |
CESC | rs10678109 | chr10:88226448 | A/AGCC | 1.6E-14 | 297 | 3.33 | 24.6 | 21.17 | KM Plot |
CESC | rs10695575 | chr10:88196173 | G/GAAC | 1.18E-14 | 298 | 3.33 | 24.9 | 21.17 | KM Plot |
CESC | rs10736338 | chr10:88239439 | T/C | 1.6E-14 | 297 | 3.33 | 24.6 | 21.17 | KM Plot |
CESC | rs10739377 | chr9:115631598 | A/G | 3.32E-5 | 299 | 21.97 | 21.18 | 4.22 | KM Plot |
CESC | rs1077497 | chr10:126723133 | C/T | 9.44E-5 | 299 | 16.38 | 25.77 | 21.23 | KM Plot |
CESC | rs10788504 | chr10:88161872 | A/G | 2.83E-14 | 293 | 3.33 | 24.3 | 21.13 | KM Plot |
CESC | rs10788508 | chr10:88214872 | T/C | 1.31E-14 | 296 | 3.33 | 24.9 | 21.17 | KM Plot |